These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33568156)

  • 1. Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future.
    O'Gorman A; Schatz E
    Harm Reduct J; 2021 Feb; 18(1):17. PubMed ID: 33568156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peer, professional, and public: an analysis of the drugs policy advocacy community in Europe.
    O'Gorman A; Quigley E; Zobel F; Moore K
    Int J Drug Policy; 2014 Sep; 25(5):1001-8. PubMed ID: 24974366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction in Europe: a framework for civil society-led monitoring.
    Rigoni R; Tammi T; van der Gouwe D; Schatz E
    Harm Reduct J; 2021 Jan; 18(1):3. PubMed ID: 33407566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
    Williamson RT; Rodd J
    BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Civil society-a leader in HIV prevention and tobacco control.
    Malinowska-Sempruch K; Bonnell R; Hoover J
    Drug Alcohol Rev; 2006 Nov; 25(6):625-32. PubMed ID: 17132578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug policy and harm reduction in the Middle East and North Africa: The role of civil society.
    Aaraj E; Jreij Abou Chrouch M
    Int J Drug Policy; 2016 May; 31():168-71. PubMed ID: 27140430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
    McDonough A; Rodríguez DC
    Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Civil society organisations and public health research--evidence from eight European union new member states.
    Knabe A; McCarthy M
    Cent Eur J Public Health; 2012 Dec; 20(4):287-93. PubMed ID: 23441396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circus monkeys or change agents? Civil society advocacy for HIV/AIDS in adverse policy environments.
    Spicer N; Harmer A; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Soc Sci Med; 2011 Dec; 73(12):1748-55. PubMed ID: 22036298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factoring civil society actors into health policy processes in low- and middle-income countries: a review of research articles, 2007-16.
    Smith SL
    Health Policy Plan; 2019 Feb; 34(1):67-77. PubMed ID: 30668676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug consumption rooms: Comparing times, spaces and actors in issues of social acceptability in French public debate.
    Jauffret-Roustide M; Cailbault I
    Int J Drug Policy; 2018 Jun; 56():208-217. PubMed ID: 29754895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Is the Role of Civil Society in Multisectoral Nutrition Governance Systems? A Multicountry Review.
    Busse H; Covic N; Aakesson A; Jogo W
    Food Nutr Bull; 2020 Jun; 41(2):244-260. PubMed ID: 32216553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Civil Society Organizations and medicines policy change: a case study of registration, procurement, distribution and use of misoprostol in Uganda.
    Atukunda EC; Brhlikova P; Agaba AG; Pollock AM
    Soc Sci Med; 2015 Apr; 130():242-9. PubMed ID: 25728484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of civil society organizations in alcohol control during the COVID-19 pandemic across six countries in Africa.
    Aneja K; Diedericks AM; Halabi S; Gottschalk K; Waddell K; Tello JE
    Discov Soc Sci Health; 2023; 3(1):17. PubMed ID: 37547258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sameness and difference: metaphor and politics in the constitution of addiction, social exclusion and gender in Australian and Swedish drug policy.
    Moore D; Fraser S; Törrönen J; Tinghög ME
    Int J Drug Policy; 2015 Apr; 26(4):420-8. PubMed ID: 25662895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Civil society engagement in multi-stakeholder dialogue: a qualitative study exploring the opinions and perceptions of MeTA members.
    Buckland-Merrett GL; Kilkenny C; Reed T
    J Pharm Policy Pract; 2017; 10():5. PubMed ID: 28070340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Civil society organisations, social innovation and health research in Europe.
    Beinare D; McCarthy M
    Eur J Public Health; 2012 Dec; 22(6):889-93. PubMed ID: 22117053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance control efforts in Africa: a survey of the role of Civil Society Organisations.
    Fraser JL; Alimi YH; Varma JK; Muraya T; Kujinga T; Carter VK; Schultsz C; Del Rio Vilas VJ
    Glob Health Action; 2021 Jan; 14(1):1868055. PubMed ID: 33475046
    [No Abstract]   [Full Text] [Related]  

  • 19. Has global fund support for civil society advocacy in the former Soviet Union established meaningful engagement or 'a lot of jabber about nothing'?
    Harmer A; Spicer N; Aleshkina J; Bogdan D; Chkhatarashvili K; Murzalieva G; Rukhadze N; Samiev A; Walt G
    Health Policy Plan; 2013 May; 28(3):299-308. PubMed ID: 22767433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing governance models and funding mechanisms of state-civil society partnerships for HIV/AIDS treatment and prevention based on lessons from Ghana.
    Hushie M
    Afr J AIDS Res; 2019 Jul; 18(2):138-147. PubMed ID: 31282299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.